A socially oriented non-financial development institution and a major organizer of international conventions, congress, exhibitions, business, social and sporting, public, and cultural events.

The Roscongress Foundation is a socially oriented non-financial development institution and a major organizer of international conventions; exhibitions; and business, public, sporting, and cultural events. It was established in pursuance of a decision by the President of the Russian Federation.

The Foundation was established in 2007 with the aim of facilitating the development of Russia’s economic potential, promoting its national interests, and strengthening the country’s image. One of the roles of the Foundation is to comprehensively evaluate, analyse, and cover issues on the Russian and global economic agendas. It also offers administrative services, provides promotional support for business projects and attracting investment, and helps foster social entrepreneurship and charitable initiatives.

Each year, the Foundation’s events draw participants from 208 countries and territories, with more than 15,000 media representatives working on-site at Roscongress’ various venues. The Foundation benefits from analytical and professional expertise provided by 5000 people working in Russia and abroad. In addition, it works in close cooperation with 155 economic partners; industrialists’ and entrepreneurs’ unions; and financial, trade, and business associations from 75 countries worldwide.

The Roscongress Foundation has Telegram channels in Russian (t.me/Roscongress), English (t.me/RoscongressDirect), and Spanish (t.me/RoscongressEsp). Official website and Information and Analytical System of the Roscongress Foundation: roscongress.org.

RC personal account
Восстановление пароля
Введите адрес электронной почты или телефон, указанные при регистрации. Вам будет отправлена инструкция по восстановлению пароля.
Некорректный формат электронной почты или телефона
Strategies to Develop the Russian Pharmaceutical Industry and Ensure National Drug Safety and Security
2 June 2021

The COVID-19 pandemic has shed light on the problem of national drug security and has given a new perspective on growth strategies for the Russian pharma industry. Self-sufficiency and the domestic development of innovations must be placed at the heart of efforts to strengthen Russia’s pharma industry. Domestic manufacturing of active pharmaceutical ingredients (API) must be built up, and an environment conducive to developing the innovative Russian pharma industry must be created. Facilitating the growth of full-cycle pharmaceutical manufacturing, as well as moving the focus of regulatory policy from building generics portfolios to creating and launching a full range of Russian-developed innovative drugs, may help achieve several goals. It could ensure the country’s drug security, and also help the competitive Russian pharma industry become a leader in global markets. What regulatory decisions and government incentives are needed to create a new competitive API industry? What forms of state support as well as statutory and regulatory innovations will help boost the innovative pharma industry in Russia? What mechanisms need to be developed to commercialize both Russian and foreign medical research and developments? What other steps to boost the national pharma industry could solve the problem of ensuring public availability of a wide range of drugs, planning the product mix, and preventing deficits? Would a protectionist policy provoke a conflict of interests, and would a strategy of offering preferences to Russian manufacturers become a barrier, limiting the market presence of international companies, and reducing the availability of drugs already registered in other markets to patients? Is the Pharma 2030 strategy capable of taking the Russian pharma industry to the international market as a confident and strong player?

Started at
Conference hall
Pavilion G, conference hall G2
Analytics on the topic